相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。US Trends in Cholesterol Screening, Lipid Levels, and Lipid-Lowering Medication Use in US Adults, 1999 to 2018
Yumin Gao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Donald M. Lloyd -Jones et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update
Jing Gu et al.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Management of Familial Hypercholesterolemia: Current Status and Future Perspectives
David T. W. Lui et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
Raul D. Santos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Evidence for improved survival with treatment of homozygous familial hypercholesterolemia
Alexandre M. Belanger et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
Rene C. Adam et al.
JOURNAL OF LIPID RESEARCH (2020)
Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia The ODYSSEY HoFH Trial
Dirk J. Blom et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Lipid-Lowering Agents Targets Beyond PCSK9
Robert A. Hegele et al.
CIRCULATION RESEARCH (2019)
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry
P. Barton Duell et al.
ATHEROSCLEROSIS (2019)
Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol
Gilbert R. Thompson et al.
EUROPEAN HEART JOURNAL (2018)
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
Mariko Harada-Shiba et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab
Aurelie Thedrez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Familial hypercholesterolemia treatments: Guidelines and new therapies
Frederick J. Raal et al.
ATHEROSCLEROSIS (2018)
Lomitapide for the treatment of hypercholesterolemia
Amanda J. Berberich et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
Robert Leipold et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
Michael France et al.
ATHEROSCLEROSIS (2016)
Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)
Sarah D. de Ferranti et al.
CIRCULATION (2016)
The Agenda for Familial Hypercholesterolemia A Scientific Statement From the American Heart Association
Samuel S. Gidding et al.
CIRCULATION (2015)
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
Viktoria Gusarova et al.
JOURNAL OF LIPID RESEARCH (2015)
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
Severe Hypertriglyceridemia With Pancreatitis Thirteen Years' Treatment With Lomitapide
Frank M. Sacks et al.
JAMA INTERNAL MEDICINE (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Marina Cuchel et al.
LANCET (2013)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
Frederick J. Raal et al.
CIRCULATION (2011)
A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia
A. David Marais et al.
ATHEROSCLEROSIS (2008)
Mechanisms of Disease: genetic causes of familial hypercholesterolemia
Anne K. Soutar et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
C Gagné et al.
CIRCULATION (2002)
Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia
FJ Raal et al.
ATHEROSCLEROSIS (2000)
分享论文
